Main characteristics of the eligible studies.
- Publication date
- Publisher
Abstract
<p><sup>a</sup>Tumor stage and percentage of advanced stage(%); NR, Not Reported; CTCs, circulating tumor cells; ICC, immunocytochemistry; RT-PCR, reverse-transcriptase polymerase chain reaction.</p><p>Main characteristics of the eligible studies.</p